Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (381-390 of 556) with videos related to

Pageof 56
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 29, 2011
Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapyYoshito Itoh, Takeshi Nishimura, Kanji Yamaguchi, et al.
Cancer Letters|July 19, 2011
High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cellsChihiro Yokomizo, Kanji Yamaguchi, Yoshito Itoh, et al.
International Journal of Cancer|January 6, 2011
Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell linesKousaku Mimura, Koji Kono, Takanori Maruyama, et al.
Investigative Radiology|December 9, 2010
Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver diseaseUtaroh Motosugi, Tomoaki Ichikawa, Katsuhiro Sano, et al.
Anaerobe|July 10, 2022
First reported case of Lachnoanaerobaculum gingivalis bacteremia in an acute myeloid leukemia patient with oral mucositis during high dose chemotherapyNaoto Okada, Akikazu Murakami, Masami Sato, et al.
Cancer Chemotherapy and Pharmacology|September 5, 2018
Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinomaAyako Iida-Ueno, Masaru Enomoto, Sawako Uchida-Kobayashi, et al.
Nephrology (Carlton, Vic.)|May 31, 2017
Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in JapanShinichi Nishi, Junichi Hoshino, Suguru Yamamoto, et al.
Journal of Viral Hepatitis|December 30, 2022
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohortRitsuzo Kozuka, Akihiro Tamori, Masaru Enomoto, et al.
Journal of Gastroenterology and Hepatology|August 31, 2018
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatmentRitsuzo Kozuka, Masaru Enomoto, Misako Sato-Matsubara, et al.
Journal of Gastroenterology|April 11, 2009
Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitisHideki Fujii, Masaru Enomoto, Wakaba Fukushima, et al.
Pageof 56

Showing results (381-390 of 556) with videos related to

Sort By:
Pageof 56
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 29, 2011
Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapyYoshito Itoh, Takeshi Nishimura, Kanji Yamaguchi, et al.
Cancer Letters|July 19, 2011
High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cellsChihiro Yokomizo, Kanji Yamaguchi, Yoshito Itoh, et al.
International Journal of Cancer|January 6, 2011
Lapatinib inhibits receptor phosphorylation and cell growth and enhances antibody-dependent cellular cytotoxicity of EGFR- and HER2-overexpressing esophageal cancer cell linesKousaku Mimura, Koji Kono, Takanori Maruyama, et al.
Investigative Radiology|December 9, 2010
Double-dose gadoxetic Acid-enhanced magnetic resonance imaging in patients with chronic liver diseaseUtaroh Motosugi, Tomoaki Ichikawa, Katsuhiro Sano, et al.
Anaerobe|July 10, 2022
First reported case of Lachnoanaerobaculum gingivalis bacteremia in an acute myeloid leukemia patient with oral mucositis during high dose chemotherapyNaoto Okada, Akikazu Murakami, Masami Sato, et al.
Cancer Chemotherapy and Pharmacology|September 5, 2018
Changes in plasma interleukin-8 and tumor necrosis factor-α levels during the early treatment period as a predictor of the response to sorafenib in patients with unresectable hepatocellular carcinomaAyako Iida-Ueno, Masaru Enomoto, Sawako Uchida-Kobayashi, et al.
Nephrology (Carlton, Vic.)|May 31, 2017
Multicentre cross-sectional study for bone-articular lesions associated with dialysis related amyloidosis in JapanShinichi Nishi, Junichi Hoshino, Suguru Yamamoto, et al.
Journal of Viral Hepatitis|December 30, 2022
Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohortRitsuzo Kozuka, Akihiro Tamori, Masaru Enomoto, et al.
Journal of Gastroenterology and Hepatology|August 31, 2018
Association between HLA-DQA1/DRB1 polymorphism and development of hepatocellular carcinoma during entecavir treatmentRitsuzo Kozuka, Masaru Enomoto, Misako Sato-Matsubara, et al.
Journal of Gastroenterology|April 11, 2009
Noninvasive laboratory tests proposed for predicting cirrhosis in patients with chronic hepatitis C are also useful in patients with non-alcoholic steatohepatitisHideki Fujii, Masaru Enomoto, Wakaba Fukushima, et al.
Pageof 56